How we make this list: we compare pricing pages, product documentation and public user reviews. Ratings come from G2, Capterra or Trustpilot, with the date we checked them.
Key takeaways
- This guide covers companies you hire for life sciences technology, not software you download, so pricing is quote-based throughout.
- Veeva and Medidata lead for clinical and regulatory work, while IQVIA leads for data, analytics, and commercial insight.
- Oracle fits organizations already running Oracle systems, and Accenture and Cognizant fit large transformation programs.
- Every vendor here needs a pilot and reference checks, since implementation quality matters as much as the platform.
- Budget for validation, training, and support, not just the license fee, since regulated work makes those costs real.
Quick comparison
| Tool | Best for | Starting price | Free plan |
|---|
 Veeva Systems | Unified pharma cloud platform | See website | Not applicable |
 IQVIA | Data, analytics, and trials | See website | Not applicable |
 Medidata | Clinical trial data and operations | See website | Not applicable |
 Oracle Life Sciences | Enterprise clinical and safety | See website | Not applicable |
 Accenture | Large transformation programs | See website | Not applicable |
 Cognizant | Life sciences services and delivery | See website | Not applicable |
 SAS | Analytics and regulatory statistics | See website | Not applicable |
 Salesforce Life Sciences | Commercial and engagement cloud | See website | Not applicable |
Is your product missing or out of date?
We review this list regularly. Vendors can request a listing, send updated pricing or ask about featured placement.
The best tech companies for life sciences solutions
Starting priceSee website
Free planNot applicable
Veeva Systems has become the default cloud platform for pharmaceutical operations, with its Vault suite covering clinical trials, regulatory submissions, quality management, and commercial content in one system. That breadth is the pitch: one vendor, one data model, and one audit trail from trial documents to approved marketing material. Large sponsors increasingly standardize on it, which means talent and integration partners are easy to find.
The cost is real. Veeva demands serious implementation effort, and smaller teams can find the platform heavy for a single study. Pricing is quote-based and shifts with modules and users, so get a written quote for your exact scope. For a pharma company planning a long-term platform rather than a one-study fix, Veeva is the safest default choice.
What we like- Industry-standard Vault platform
- Clinical, regulatory, quality, and commercial in one cloud
- Strong pharma adoption
Watch out for- Significant investment and implementation effort
- Smaller teams may find it heavy
- Pricing is quote-based
Starting priceSee website
Free planNot applicable
IQVIA combines clinical research services with healthcare data and analytics at a scale no rival matches. In August 2026 it was ranked number one in Everest Group's Top 50 Pharmaceutical Technology Providers report, the only provider with technology coverage across all six pharma value-chain areas assessed, from drug discovery to commercial operations. Its data assets power trial feasibility, site selection, and commercial analytics that smaller vendors cannot replicate.
That scale suits large sponsors best. Smaller biotechs may find IQVIA engagements service-heavy and priced for enterprise scope. If your need is data-driven decisions across research, trials, and commercial work, IQVIA is the strongest all-round partner, and its 2026 Everest ranking backs that claim with an independent score.
What we like- Ranked number one pharma tech provider by Everest Group in 2026
- Huge healthcare data assets
- Broad value-chain coverage
Watch out for- Scale suits large sponsors best
- Service-heavy engagements
- Pricing is quote-based
Starting priceSee website
Free planNot applicable
Medidata, a Dassault Systemes brand, is the clinical trial specialist on this list. Its platform covers electronic data capture, study management, and trial analytics, and in September 2026 IDC MarketScape named it a Leader for life sciences research and development real-world data platforms, the only company focused only on trials to reach that category. Its data assets span more than 42,000 trials and 13 million patients, which feed external control arms and efficacy benchmarks.
For complex global trials, Medidata is a top-two pick alongside Veeva, with particular strength in data analytics and AI. Setup for complex protocols needs expert help, and pricing is quote-based. If your bottleneck is trial data quality and speed, Medidata deserves the first pilot slot.
What we like- Leader in clinical data capture and analytics
- AI and real-world data strength
- 42,000 plus trials in data assets
Watch out for- Owned by Dassault Systemes, so roadmap ties to a larger group
- Complex trials need expert setup
- Quote-based pricing
#4
Oracle Life Sciences
Best for: Enterprise clinical and safety
Visit oracle.com
Starting priceSee website
Free planNot applicable
Oracle Life Sciences covers clinical trials through Clinical One and pharmacovigilance through Argus, its safety suite entrenched at many large companies. One analyst comparison put Oracle at about 28.5 percent of the e-clinical market, the largest share in that report, which reflects how many large sponsors already run Oracle systems for trials and safety.
Oracle fits best inside organizations already running Oracle infrastructure, where integration is simpler and support is unified. Outside that estate, its architecture can feel older than Veeva or Medidata cloud offerings, and implementation is a major program rather than a quick rollout. For an Oracle shop, it is the natural pick. For a greenfield biotech, compare it closely against Veeva first.
What we like- Clinical One unified trial platform
- Argus safety suite deeply entrenched
- Enterprise integration
Watch out for- Best inside Oracle estates
- Older architecture in places
- Implementation is a major program
Starting priceSee website
Free planNot applicable
Accenture is a services partner rather than a single product vendor, and that distinction matters. Its life sciences practice runs large transformation programs: cloud migration, AI adoption, data modernization, and commercial transformation across global pharma companies. When the problem spans many systems and many countries, Accenture brings program management and delivery scale that product vendors do not.
Rates are premium, and the work suits large programs better than narrow tool picks. Outcomes depend heavily on the specific team assigned, so interview the delivery leads, not just the sales team, and check references from similar programs. For a multi-year transformation, Accenture is a strong shortlist name.
What we like- Deep life sciences practice
- AI and cloud transformation scale
- Global delivery
Watch out for- Premium rates
- Large-program focus
- Outcomes depend heavily on the assigned team
Starting priceSee website
Free planNot applicable
Cognizant is another services-led partner with a large life sciences practice, covering research and development support, commercial operations, and technology delivery. It often prices below the top-tier strategy firms while still staffing global delivery teams, which suits mid-size pharma companies that need solid execution without premium consulting rates.
The honest limit is variation: service quality depends on the engagement team, and Cognizant does not own a flagship product platform like Veeva Vault. Use it where you need delivery capacity and domain experience, and pair it with a product vendor for the platform itself. Reference checks on similar projects are essential before signing.
What we like- Large life sciences delivery practice
- Commercial and R and D services
- Competitive rates versus top-tier rivals
Watch out for- Quality varies by engagement
- Less product depth than Veeva or Medidata
- Quote-based pricing
#7
SAS
Best for: Analytics and regulatory statistics
Visit sas.com
Starting priceSee website
Free planNot applicable
SAS has been the statistical backbone of pharma for decades, and regulatory submissions still lean on SAS analyses more than any other tool. Its analytics platform covers clinical statistics, safety signal detection, and real-world evidence work, with a track record that regulators know well. For biostatistics teams, SAS is less a choice than an expectation.
Licensing costs are significant, and the platform needs specialist skills to run well. SAS is not a full trial operations suite, so it complements Veeva or Medidata rather than replacing them. If your submission pipeline depends on statistical rigor, SAS belongs in the stack regardless of which trial platform you pick.
What we like- Gold standard for regulatory statistical analysis
- Deep analytics and AI tooling
- Long pharma track record
Watch out for- Licensing costs
- Specialist skills needed
- Less of a full trial operations suite
Starting priceSee website
Free planNot applicable
Salesforce Life Sciences Cloud targets the commercial side of pharma: healthcare professional engagement, patient programs, and commercial analytics, built on the Salesforce platform with Data Cloud connectivity. Its AI capabilities continue to expand, and teams already running Salesforce for other functions get a smoother fit.
Clinical depth trails the trial specialists, so Salesforce is a commercial pick, not a trial platform. For a company whose bottleneck is engaging doctors and patients rather than running studies, it is a strong choice, especially alongside Veeva or IQVIA data. Price it as a platform plus implementation, since Salesforce projects rarely end at the license fee.
What we like- Life Sciences Cloud for commercial engagement
- Data Cloud connectivity
- Strong CRM heritage
Watch out for- Clinical depth trails Veeva and Medidata
- AI features still expanding
- Quote-based pricing
How we chose
We treated this topic as companies you hire, stated plainly, since "best tech companies" means vendors and partners rather than apps you install. We compared vendor platforms, analyst rankings such as Everest Group 2026 and IDC MarketScape 2026, and published market reports, and we favored companies with current life sciences focus and verifiable 2026 standing. All pricing is quote-based, so we use "See website" throughout rather than inventing figures, and we left out vendors with no clear life sciences practice.
How to pick a life sciences tech partner
Start with the bottleneck, not the vendor ranking. If trials are the problem, shortlist Veeva and Medidata. If data and commercial insight are the problem, shortlist IQVIA and Salesforce. If the problem is a multi-system transformation, talk to Accenture or Cognizant. One vendor rarely fixes every area, so expect a stack, not a single purchase.
Run a real pilot
Ask each finalist to run a pilot on your own data and your own protocol, with your own users in the room. Check validation support, since regulated work needs documented validation, and confirm training and support terms in writing. Talk to two reference customers of similar size, and ask what went wrong, not just what went well. A vendor that hides its failures will repeat them on your program.
Budget the full cost
License fees are only part of the bill. Add implementation, validation, data migration, training, and ongoing support, and ask each vendor to quote those lines separately. Multi-year contracts should include exit terms and data export rights, since switching a validated trial platform mid-program is costly. Get the total three-year cost in writing before you compare vendors head to head.
Frequently asked questions
Are these companies or software products?
Both, depending on the name. Veeva, Medidata, Oracle, SAS, and Salesforce sell platforms, while IQVIA, Accenture, and Cognizant combine platforms with large services practices. This guide treats them as partners you hire, since enterprise life sciences work always mixes software and services.
Which company is best for clinical trials?
Veeva and Medidata lead for trial data and operations, with Medidata strongest on analytics and real-world data and Veeva strongest on a unified cloud across clinical, regulatory, and quality. Oracle Clinical One is the pick inside Oracle estates.
How much do these solutions cost?
All are quote-based, so "See website" is the honest answer. Budget on implementation, validation, training, and support as well as licenses, and ask each vendor for a three-year total cost for your exact scope.
Do small biotechs need these enterprise vendors?
Not always. Small teams running a single study often do better with lighter tools such as Castor or RealTime, which suit smaller budgets. Move to Veeva or Medidata when trial complexity, country count, or regulatory scrutiny outgrows a light tool.
What should I check before signing?
Validation support, data export and exit terms, reference customers of your size, and the named delivery team. Confirm training and support in writing, and run a pilot on your own data before committing to a multi-year contract.
Sources we checked (8)
- https://www.veeva.com
- https://www.iqvia.com
- https://www.medidata.com
- https://www.oracle.com
- https://www.accenture.com
- https://www.cognizant.com
- https://www.sas.com
- https://www.salesforce.com
Is your product missing or out of date?
We review this list regularly. Vendors can request a listing, send updated pricing or ask about featured placement.
Shihab Mia · Founder, Rankite
Shihab has 5+ years in B2B and SaaS SEO. He writes Rankite's software buying guides from pricing pages, documentation and public user reviews. More about Shihab.